Study to Evaluate Iovera®° in Adult Patients Undergoing Total Knee Arthroplasty

NATerminatedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

September 30, 2020

Primary Completion Date

May 13, 2022

Study Completion Date

July 12, 2022

Conditions
Post-Operative Pain Management
Interventions
DEVICE

ioveraº

Cryoneurolysis

DEVICE

ioveraº sham

ioveraº sham

Trial Locations (7)

10075

Northwell Health, New York

21204

Towson Orthopaedic Associates, Towson

33321

Phoenix Clinical Research, Tamarac

75006

Legent Orthopedic Hospital, Carrollton

77401

First Surgical Hospital, Bellaire

91105

Lotus Clinical Research, Pasadena

94538

Sah Orthopaedic Associates at the Institute for Joint Restoration, Fremont

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY

NCT04191031 - Study to Evaluate Iovera®° in Adult Patients Undergoing Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter